Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells.
Yagolovich A, Kuskov A, Kulikov P, Kurbanova L, Bagrov D, Artykov A, Gasparian M, Sizova S, Oleinikov V, Gileva A, Kirpichnikov M, Dolgikh D, Markvicheva E. Yagolovich A, et al. Among authors: gileva a. Pharmaceutics. 2021 Sep 7;13(9):1413. doi: 10.3390/pharmaceutics13091413. Pharmaceutics. 2021. PMID: 34575490 Free PMC article.
Effect of lipopeptide structure on gene delivery system properties: Evaluation in 2D and 3D in vitro models.
Koloskova OO, Gileva AM, Drozdova MG, Grechihina MV, Suzina NE, Budanova UA, Sebyakin YL, Kudlay DA, Shilovskiy IP, Sapozhnikov AM, Kovalenko EI, Markvicheva EA, Khaitov MR. Koloskova OO, et al. Among authors: gileva am. Colloids Surf B Biointerfaces. 2018 Jul 1;167:328-336. doi: 10.1016/j.colsurfb.2018.04.003. Epub 2018 Apr 7. Colloids Surf B Biointerfaces. 2018. PMID: 29684902
DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma.
Yagolovich AV, Isakova AA, Artykov AA, Vorontsova YV, Mazur DV, Antipova NV, Pavlyukov MS, Shakhparonov MI, Gileva AM, Markvicheva EA, Plotnikova EA, Pankratov AA, Kirpichnikov MP, Gasparian ME, Dolgikh DA. Yagolovich AV, et al. Among authors: gileva am. Int J Mol Sci. 2022 Oct 21;23(20):12687. doi: 10.3390/ijms232012687. Int J Mol Sci. 2022. PMID: 36293545 Free PMC article.
Correlative Fluorescent Scanning Probe Nanotomography Used to Study the Intracellular Distribution of Doxorubicin in MCF-7 Human Breast Adenocarcinoma Cells.
Agapova OI, Efimov AE, Mochalov KE, Solovyeva DO, Gileva AM, Markvicheva EA, Yakovlev DV, Lyundup AV, Oleinikov VA, Agapov II, Gautier SV. Agapova OI, et al. Among authors: gileva am. Dokl Biol Sci. 2023 Apr;509(1):103-106. doi: 10.1134/S0012496623700266. Epub 2023 May 19. Dokl Biol Sci. 2023. PMID: 37208575
Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome.
Tchesnokova V, Billig M, Chattopadhyay S, Linardopoulou E, Aprikian P, Roberts PL, Skrivankova V, Johnston B, Gileva A, Igusheva I, Toland A, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Kahl B, Price LB, Weissman SJ, Limaye A, Scholes D, Johnson JR, Sokurenko EV. Tchesnokova V, et al. Among authors: gileva a. J Clin Microbiol. 2013 Sep;51(9):2991-9. doi: 10.1128/JCM.00984-13. Epub 2013 Jul 10. J Clin Microbiol. 2013. PMID: 23843485 Free PMC article.